5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 32.12▼ | 32.12▼ | 32.12▼ | 32.05▼ | 30.94▼ |
MA10 | 31.14▲ | 31.14▲ | 31.14▲ | 31.57▼ | 30.63▼ |
MA20 | 29.67▲ | 29.67▲ | 29.63▲ | 30.91▼ | 34.36▼ |
MA50 | N/A | N/A | N/A | 30.63▼ | N/A |
MA100 | N/A | N/A | N/A | 34.33▼ | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.814▲ | 0.890▲ | 1.077▲ | 0.128▲ | N/A |
RSI | 56.709▲ | 56.755▲ | 55.525▲ | 46.927▼ | 42.391▼ |
STOCH | 71.219 | 71.219 | 71.219 | 65.742 | 46.546 |
WILL %R | -18.284▲ | -18.284▲ | -18.284▲ | -64.739 | -56.708 |
CCI | 71.339 | 71.339 | 71.339 | -14.864 | -22.251 |
Wednesday, September 24, 2025 01:37 PM
Novo Nordisk A/S (NYSE: NVO) is among the best safe stocks to buy now. Park Avenue Securities LLC acquired a new stake in Novo Nordisk A/S (NYSE:NVO) through the purchase of 85,970 shares of the ...
|
Monday, September 22, 2025 03:56 AM
It has been an unpredictable ride lately for Novo Nordisk (NYSE:NVO), and investors may be pausing to ask themselves what, if anything, the latest market action signals. Without a major headline ...
|
Sunday, September 21, 2025 07:15 AM
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/09/25 | 31.05 | 31.06 | 30.5608 | 30.5608 | 1,849 |
24/09/25 | 31.72 | 31.85 | 31.51 | 31.8254 | 1,207 |
23/09/25 | 32.50 | 32.50 | 31.77 | 31.9939 | 2,089 |
22/09/25 | 33.00 | 33.00 | 32.4802 | 32.6711 | 4,775 |
19/09/25 | 33.61 | 33.61 | 32.71 | 33.2027 | 19,409 |
18/09/25 | 33.30 | 33.44 | 33.10 | 33.313 | 5,200 |
17/09/25 | 31.00 | 31.67 | 31.00 | 31.2278 | 3,632 |
16/09/25 | 30.51 | 30.76 | 30.51 | 30.6436 | 5,116 |
15/09/25 | 30.39 | 30.39 | 30.2339 | 30.2339 | 788 |
12/09/25 | 29.94 | 30.06 | 29.695 | 30.025 | 2,000 |
|
|
||||
|
|
||||
|
|